Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix
Clinical trial NCT03305341 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03305341
- Sponsor
- Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-18
- Primary completion
- 2026-11-18
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.